Skip to main content
. 2022 Apr 14;12(8):1346. doi: 10.3390/nano12081346

Figure 1.

Figure 1

Biological monitoring of nanomaterials in human samples could fill a gap and help better understand the relationship between exposure to nanomaterials and adverse effects through the analysis of both biomarkers of exposure and biomarkers of effects.